{"id":"NCT00741156","sponsor":"The Hospital for Sick Children","briefTitle":"The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution","officialTitle":"The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution After the Bidirectional Cavopulmonary Connection","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-07","primaryCompletion":"2010-01","completion":"2010-01","firstPosted":"2008-08-26","resultsPosted":"2015-12-18","lastUpdate":"2015-12-18"},"enrollment":12,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hypertension","Congestive Cardiomyopathy"],"interventions":[{"type":"DRUG","name":"Enalaprilat","otherNames":["Vasotec"]}],"arms":[{"label":"Enalaprilat","type":"EXPERIMENTAL"}],"summary":"The primary objective of this study is to study the acute effects of angiotensin-converting enzyme inhibitor (ACEI) on systemic, pulmonary and cerebral blood flow in post bidirectional cavopulmonary connection (BCPC) patients.","primaryOutcome":{"measure":"Systemic, Pulmonary and Cerebral Blood Flow at Baseline and After Enalaprilat","timeFrame":"Baseline and after enalaprilat","effectByArm":[{"arm":"Systemic Blood Flow Baseline","deltaMin":1.4,"sd":null},{"arm":"Systemic Blood Flow After Enalaprilat","deltaMin":1.8,"sd":null},{"arm":"Pulmonary Blood Flow Baseline","deltaMin":1.9,"sd":null},{"arm":"Pulmonary Blood Flow After Enaliprilat","deltaMin":1.9,"sd":null},{"arm":"Cerebral Blood Flow Baseline","deltaMin":1.9,"sd":null},{"arm":"Cerebral Blood Flow After Enalaprilat","deltaMin":1.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.09"}]},"eligibility":{"minAge":"2 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":1},"locations":{"siteCount":1,"countries":["Canada"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":12},"commonTop":[]}}